Covaxin Works Against UK Strain, Variant Found in India: Bharat Biotech | Read
Bharat Biotech has said its vaccine Covaxin is effective against the aggressively virulent B.1.167 strain of Covid detected in India and the UK variant of the virus B.1.1.7. The study -- conducted by India's National Institute of Virology and the Indian Council of Medical Research -- has been published in a peer-reviewed journal, Clinical Infectious Diseases. Bharat Biotech said according to the research, Covaxin "produced neutralising titres (meaning the concentration of antibodies) against all key emerging variants".
